Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0039 | 0.0504 | 0.0504 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0105 | 0.5371 | 0.5 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0158 | 0.9259 | 0.9259 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0067 | 0.2553 | 0.2757 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0046 | 0.103 | 1 |
Giardia lamblia | Kinase, PLK | 0.0105 | 0.5371 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0039 | 0.0504 | 0.0504 |
Schistosoma mansoni | hypothetical protein | 0.0079 | 0.3434 | 0.3434 |
Trypanosoma brucei | polo-like protein kinase | 0.0105 | 0.5371 | 0.5 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0105 | 0.5371 | 0.5801 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0046 | 0.103 | 0.103 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0043 | 0.0745 | 0.1386 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0105 | 0.5371 | 0.5801 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.1713 | 0.185 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.5371 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0105 | 0.5371 | 1 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0043 | 0.0745 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.5371 | 1 |
Brugia malayi | hypothetical protein | 0.0079 | 0.3434 | 0.3709 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.5371 | 1 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0045 | 0.0939 | 0.0939 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0158 | 0.9259 | 1 |
Echinococcus multilocularis | peregrin | 0.0036 | 0.0286 | 0.0286 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0079 | 0.3434 | 0.3434 |
Echinococcus granulosus | peregrin | 0.0036 | 0.0286 | 0.0286 |
Echinococcus multilocularis | geminin | 0.0168 | 1 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0105 | 0.5371 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0105 | 0.5371 | 0.5371 |
Echinococcus granulosus | jumonji domain containing protein | 0.0045 | 0.0939 | 0.0939 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.5371 | 1 |
Schistosoma mansoni | jumonji domain containing protein | 0.0085 | 0.3841 | 0.3841 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0105 | 0.5371 | 0.5371 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0105 | 0.5371 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 1 | 1 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0154 | 0.8932 | 0.8932 |
Loa Loa (eye worm) | acetyltransferase | 0.0158 | 0.9259 | 1 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0039 | 0.0504 | 0.0545 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0158 | 0.9259 | 0.9259 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0105 | 0.5371 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.5371 | 1 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0039 | 0.0504 | 0.0504 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0079 | 0.3434 | 0.3434 |
Entamoeba histolytica | hypothetical protein | 0.0079 | 0.3434 | 0.5814 |
Brugia malayi | jmjC domain containing protein | 0.0039 | 0.0504 | 0.0545 |
Brugia malayi | Bromodomain containing protein | 0.0036 | 0.0286 | 0.0308 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0046 | 0.103 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0079 | 0.3434 | 0.5814 |
Entamoeba histolytica | hypothetical protein | 0.0079 | 0.3434 | 0.5814 |
Schistosoma mansoni | kinase | 0.0054 | 0.1551 | 0.1551 |
Brugia malayi | jmjC domain containing protein | 0.0107 | 0.5455 | 0.5892 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0105 | 0.5371 | 0.5371 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0107 | 0.5455 | 0.5455 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0079 | 0.3434 | 0.3434 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0052 | 0.1448 | 0.0962 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.5371 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0105 | 0.5371 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0079 | 0.3434 | 0.5814 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0046 | 0.103 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0052 | 0.1448 | 0.0962 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0107 | 0.5455 | 0.5455 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0039 | 0.0504 | 0.0504 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 2.42 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 3.12 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 4.63 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 5 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 8 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 100 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 100 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 2.26 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 5 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 8 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 100 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 101 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 6.06 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 0.865 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.